These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7003277)

  • 1. [Viral hepatitis effect on renal graft survival (author's transl)].
    Bosković S; Grinfeld B; Jelić J
    Lijec Vjesn; 1980 May; 102(5):243-5. PubMed ID: 7003277
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft survival and response to hepatitis-B virus in kidney recipients.
    Toussaint C; Cappel R; Vereerstraeten P; Kinnaert P; Dupont E; Van Geertruyden J
    Transplant Proc; 1979 Mar; 11(1):89-92. PubMed ID: 377722
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term survival in living related donor renal allograft recipients with hepatitis B infection.
    Roy DM; Thomas PP; Dakshinamurthy KV; Jacob CK; Shastry JC
    Transplantation; 1994 Jul; 58(1):118-9. PubMed ID: 8036701
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical outcome of HBsAg(+) renal allograft recipients.
    Kang SW; Lee SW; Choi KH; Han KH; Lee HY; Han DS; Kim YS; Park K
    Transplant Proc; 1996 Jun; 28(3):1653-4. PubMed ID: 8658823
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic significance of hepatitis B surface antigenemia in cadaveric renal transplant patients.
    Rivolta E; De Vecchi A; Tarantino A; Castelnovo C; Berardinelli L; Ponticelli C
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2153-4. PubMed ID: 3274481
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal transplantation in hepatitis B surface antigen-positive patients: single-center experience in Korea.
    Kim YG; Kim S; Lee JH; Kim YK; Han JS; Lee JS; Kim SJ; Kim ST
    Transplant Proc; 1994 Aug; 26(4):2143-5. PubMed ID: 8066701
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B antigen infection and graft survival in cadaveric renal transplantation.
    Rashid A; Sengar DP; Couture RA; Jindal S; Posen G
    Trans Am Soc Artif Intern Organs; 1977; 23():433-6. PubMed ID: 333699
    [No Abstract]   [Full Text] [Related]  

  • 8. Follow-up of renal allograft recipients from HBsAg positive donors. GCIF.
    Antoine C; Bedrossian J; Binet I; Schenmetzeler C; Selami F; François A
    Transplant Proc; 1995 Apr; 27(2):1725-6. PubMed ID: 7725471
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of hepatitis B and C virus on kidney transplantation outcome.
    Mathurin P; Mouquet C; Poynard T; Sylla C; Benalia H; Fretz C; Thibault V; Cadranel JF; Bernard B; Opolon P; Coriat P; Bitker MO
    Hepatology; 1999 Jan; 29(1):257-63. PubMed ID: 9862875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatopathies in renal transplants].
    Matesanz Acedos R; Frutos Sanz MA; Moreno Caparros A; Navarro Izquierdo A; Liaño García F; Casado Pérez S; Egido de los Rios J; Hernando Avendaño L
    Rev Clin Esp; 1977 Nov; 147(3):239-44. PubMed ID: 343196
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience.
    Murakami R; Amada N; Sato T; Orii T; Kikuchi H; Haga I; Ohashi Y; Okazaki H
    Clin Transplant; 2006; 20(3):351-8. PubMed ID: 16824154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
    Chan TM; Fang GX; Tang CS; Cheng IK; Lai KN; Ho SK
    Hepatology; 2002 Nov; 36(5):1246-52. PubMed ID: 12395336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome.
    Berber I; Aydin C; Yigit B; Turkmen F; Titiz IM; Altaca G
    Transplant Proc; 2005 Dec; 37(10):4173-5. PubMed ID: 16387070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney transplantation from hepatitis B surface antigen-positive donors into hepatitis B surface antigen-positive recipients: preliminary findings.
    Veroux M; Puliatti C; Macarone M; Cappello D; Gagliano M; Spataro M; Di Mare M; Giuffrida G; Veroux P
    Transplant Proc; 2005; 37(6):2467-8. PubMed ID: 16182711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of donor hepatitis B antigenemia on renal allograft in hepatitis B recipients.
    Chen JB; Hsieh H; Hsu KT; Chen CH
    Transplant Proc; 1996 Jun; 28(3):1490-2. PubMed ID: 8658755
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen.
    Ahn HJ; Kim MS; Kim YS; Kim SI; Huh KH; Ju MK; Ahn SH; Han KH
    J Med Virol; 2007 Nov; 79(11):1655-63. PubMed ID: 17854044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors on graft survival of living donor kidney transplantation in a single center.
    Jin DC; Yoon YS; Kim YS; Yoon SA; Ahn SJ; Kim SY; Chang YS; Bang BK; Koh YB
    Clin Transplant; 1996 Dec; 10(6 Pt 1):471-7. PubMed ID: 8996765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
    Gwak GY; Huh W; Lee DH; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Oh HY
    Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of subsequent splenectomy on the rejection of allotransplanted dog kidney (author's transl)].
    Málek P; Kolc J; Holub M
    Cas Lek Cesk; 1976 Dec; 115(48):1477-9. PubMed ID: 793717
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C infection among renal transplant recipients: a comparative study using first- and second-generation anti-HCV EIA and HCV detection by nested PCR.
    Cheng IK; Chan DT; Lok AS
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1460-2. PubMed ID: 7680161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.